Literature DB >> 1320854

Expression and amplification of cellular oncogenes in human developing placenta and neoplastic trophoblastic tissue.

J S Park1, S E Namkoong, H Y Lee, S J Kim, K J Hong, I S Kim, K U Kim, B S Shim.   

Abstract

To confirm the expression of cellular oncogenes during normal development, their differential RNA levels in developing human placenta have been studied using radioactive probes such as v-abl, v-erbA, v-fms, v-mos, v-myc, N-ras and v-src. The c-mos and N-ras genes are expressed and amplified at high levels especially in term placenta, while c-abl, and c-erbA are expressed constantly during development. These findings indicate that c-mos and N-ras genes may be closely linked to normal differentiation, although c-abl and c-erbA may participate in overall developmental processes. In contrast, transcripts of c-myc and c-src are enhanced at first trimester and decreased sequentially thereafter, showing that these genes may play a role in early proliferation. Expression patterns of c-fms gene are same as that of c-myc and c-src except reelevation at term. In addition, to characterize the effect of cellular oncogene expression has been also examined in hydatidiform mole and tumor cells such as BeWo and choriocarcinoma. All cellular oncogenes examined in this study were significantly overexpressed. Thus, our results suggest that cellular oncogene activation may be strongly associated with neoplastic change of trophoblast.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320854     DOI: 10.1111/j.1447-0756.1992.tb00300.x

Source DB:  PubMed          Journal:  Asia Oceania J Obstet Gynaecol        ISSN: 0389-2328


  2 in total

1.  Mutations in the gene encoding the alpha-subunit of the Gs protein in molar pregnancy.

Authors:  G Garon; J G LeHoux; P Bessette
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

2.  Decreased expression of Ras GTPase activating protein in human trophoblastic tumors.

Authors:  M Ståhle-Bäckdhal; M Inoue; J Zedenius; B Sandstedt; L DeMarco; F Flam; C Silfverswärd; J Andrade; E Friedman
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.